vTv Therapeutics Inc.
VTVT
$15.35
-$0.65-4.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.67% | -4.49% | 28.12% | 7.81% | -8.14% |
| Total Depreciation and Amortization | -59.09% | -4.35% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 52.58% | 99.46% | -119.83% | 69.25% | 78.22% |
| Change in Net Operating Assets | 82.53% | -194.01% | -2,589.58% | -180.08% | -201.74% |
| Cash from Operations | 22.47% | -65.58% | -32.77% | -9.11% | -41.99% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 100.00% | -- | 14.73% |
| Issuance of Common Stock | -- | -- | -- | -- | 318.41% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 100.00% | 420.72% | -- | 324.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -113.28% | -499.42% | 9.31% | -9.11% | 544.71% |